UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 517

Sortiert nach

Editorial “Parkinsonism across the spectrum of movement disorders and beyond”

Journal of the neurological sciences, 2022-02, Vol.433, p.120013-120013, Article 120013

2022

Link zum Volltext

Verfügbarkeit prüfen

International Neurology

Second edition., 2016

Link zum Volltext

Verfügbarkeit prüfen

Amiloride but not memantine reduces neurodegeneration, seizures and myoclonic jerks in rats with cardiac arrest-induced global cerebral hypoxia and reperfusion

PloS one, 2013-04, Vol.8 (4), p.e60309-e60309

2013

Link zum Volltext

Verfügbarkeit prüfen

Parkinsonism in viral, paraneoplastic, and autoimmune diseases

Journal of the neurological sciences, 2022-02, Vol.433, p.120014-120014, Article 120014

2022

Link zum Volltext

Verfügbarkeit prüfen

Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia

Clinical parkinsonism & related disorders, 2022-01, Vol.7, p.100160-100160, Article 100160

2022

Link zum Volltext

Verfügbarkeit prüfen

Medications used to treat tremors

Journal of the neurological sciences, 2022-04, Vol.435, p.120194-120194, Article 120194

2022

Link zum Volltext

Verfügbarkeit prüfen

Motor complications in Parkinson disease: Clinical manifestations and management

Journal of the neurological sciences, 2008-03, Vol.266 (1), p.204-215

2008

Link zum Volltext

Verfügbarkeit prüfen

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease

Clinical interventions in aging, 2009-01, Vol.4, p.109-113

Truong, Daniel D

2009

Link zum Volltext

Verfügbarkeit prüfen

Orofacial dystonia and associated bulbar symptoms in multiple system atrophy: A blinded video analysis

Journal of the neurological sciences, 2020-10, Vol.417, p.116995-116995, Article 116995

2020

Link zum Volltext

Verfügbarkeit prüfen

Levodopa-induced dyskinesia: clinical features, incidence, and risk factors

Journal of Neural Transmission, 2018-08, Vol.125 (8), p.1109-1117

2018

Link zum Volltext

Verfügbarkeit prüfen

The nosology of tardive syndromes

Journal of the neurological sciences, 2018-06, Vol.389, p.10-16

2018

Link zum Volltext

Verfügbarkeit prüfen

Setting the record straight: The nosology of tardive syndromes

Parkinsonism & related disorders, 2019-02, Vol.59, p.146-150

2019

Link zum Volltext

Verfügbarkeit prüfen

Hallucinations and the spectrum of psychosis in Parkinson's disease

Journal of the neurological sciences, 2017-03, Vol.374, p.56-62

2017

Link zum Volltext

Verfügbarkeit prüfen

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial

JAMA neurology, 2017-08, Vol.74 (8), p.941

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN® , botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia

Journal of the neurological sciences, 2011-09, Vol.308 (1), p.103-109

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of Gα(olf) in familial and sporadic adult-onset primary dystonia

Human molecular genetics, 2013-06, Vol.22 (12), p.2510-2519

2013

Link zum Volltext

Verfügbarkeit prüfen

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

CNS drugs, 2018-04, Vol.32 (4), p.387-398

2018

Link zum Volltext

Verfügbarkeit prüfen

Management of non-motor symptoms in advanced Parkinson disease

Journal of the neurological sciences, 2008-03, Vol.266 (1), p.216-228

2008

Link zum Volltext

Verfügbarkeit prüfen

Role of G[alpha](olf) in familial and sporadic adult-onset primary dystonia

Human molecular genetics, 2013-06, Vol.22 (12), p.2510-2519

2013

Link zum Volltext

Verfügbarkeit prüfen

The sleeping brain in Parkinson's disease: A focus on REM sleep behaviour disorder and related parasomnias for practicing neurologists

Journal of the neurological sciences, 2017-03, Vol.374, p.32-37

2017

Link zum Volltext

Verfügbarkeit prüfen

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

Parkinsonism & related disorders, 2019-07, Vol.64, p.175-180

2019

Link zum Volltext

Verfügbarkeit prüfen

NMDA receptor-mediated excitotoxicity contributes to the cerebral hypoxic injury of a rat model of posthypoxic myoclonus

Brain research, 2007-02, Vol.1133 (1), p.209-215

2007

Link zum Volltext

Verfügbarkeit prüfen

Editorial and introduction: Behavioral aspects of Parkinson's disease

Journal of the neurological sciences, 2017-03, Vol.374, p.1-2

2017

Link zum Volltext

Verfügbarkeit prüfen

The natural history of embouchure dystonia

Movement disorders, 2001-09, Vol.16 (5), p.899-906

2001

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic strategies for nonmotor symptoms in early Parkinson's disease: the case for a higher priority and stronger evidence

Parkinsonism & related disorders, 2012, Vol.18, p.S110-S113

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 517

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(483)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Movement Disorders
(21)
Journal Of The Neurological Sciences
(16)
Parkinsonism & Related Disorders
(9)
Brain Research
(6)
European Journal Of Pharmacology
(6)
Human Genetics
(6)
Toxicon
(6)
Plos One
(5)
Pm & R
(5)
Arthritis & Rheumatology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Editorial “Parkinsonism across the spectrum of movement disorders and beyond”

International Neurology

Amiloride but not memantine reduces neurodegeneration, seizures and myoclonic jerks in rats with cardiac arrest-induced global cerebral hypoxia and reperfusion

Parkinsonism in viral, paraneoplastic, and autoimmune diseases

Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia

Medications used to treat tremors

Motor complications in Parkinson disease: Clinical manifestations and management

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease

Orofacial dystonia and associated bulbar symptoms in multiple system atrophy: A blinded video analysis

Levodopa-induced dyskinesia: clinical features, incidence, and risk factors

The nosology of tardive syndromes

Setting the record straight: The nosology of tardive syndromes

Hallucinations and the spectrum of psychosis in Parkinson's disease

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN® , botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia

Role of Gα(olf) in familial and sporadic adult-onset primary dystonia

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

Management of non-motor symptoms in advanced Parkinson disease

Role of G[alpha](olf) in familial and sporadic adult-onset primary dystonia

The sleeping brain in Parkinson's disease: A focus on REM sleep behaviour disorder and related parasomnias for practicing neurologists

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

NMDA receptor-mediated excitotoxicity contributes to the cerebral hypoxic injury of a rat model of posthypoxic myoclonus

Editorial and introduction: Behavioral aspects of Parkinson's disease

The natural history of embouchure dystonia

Therapeutic strategies for nonmotor symptoms in early Parkinson's disease: the case for a higher priority and stronger evidence

Suchergebnisse filtern